Headed to ARVO? You’re invited to dinner CME. Or, join virtually!
May 7, 2024
May 7, 2024
2024 Featured Articles May 23 – Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different…
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
DeFilipp Z, Damania AV, Kim HT, et al. Third-Party Fecal Microbiota Transplantation for High-Risk Treatment-Naive Acute GVHD of the Lower GI Tract. Blood Advances. 2024;…
Supported by an independent educational grant from AbbVie Inc. Join Drs Camidge and Dagogo-Jack in Chicago as they discuss the latest information on MET-altered NSCLC.…
Lily Scourfield, MBBCh, King’s College Hospital, London, UK, outlines the findings from a four-year tertiary center experience of intensive care unit (ICU) outcomes in patients…
Kian-Huat Lim, MD, PhD, discusses the importance of multidisciplinary collaboration when diagnosing and treating patients with pancreatic cancer.
Craig Eckfeldt, MD, PhD, discusses key updates in the MDS treatment paradigm and the implications of MRD testing, as well as next steps in the…
S. Vincent Rajkumar, MD, discusses highly anticipated abstracts in multiple myeloma that will be presented at the 2024 ASCO Annual Meeting.
An abstract is unavailable.
Two biosimilars for reference denosumab have received marketing authorization from the European Commission.